Trichuris Suis Ova in Autism Spectrum Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Autism
Interventions
DRUG

Trichuris Suis Ova

TSO will be administered in vials prepared by Coronado Biosciences. Vials will be diluted with a commercial drink and given to subjects to ingest. Subjects will receive a dose of 2500 ova every two weeks for 12 weeks.

Trial Locations (1)

10467

Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx

All Listed Sponsors
collaborator

Simons Foundation

OTHER

lead

Montefiore Medical Center

OTHER

NCT01040221 - Trichuris Suis Ova in Autism Spectrum Disorders | Biotech Hunter | Biotech Hunter